Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025
Lifecore Biomedical (NASDAQ: LFCR), a contract development and manufacturing organization (CDMO), has scheduled its second quarter fiscal 2025 financial results announcement for January 2, 2025, after market close. The company's senior management will host a webcast at 4:30 p.m. Eastern Time to discuss the quarterly results and recent corporate developments. The webcast will be accessible through Lifecore's investor relations website, with a replay available for at least 14 days following the live presentation.
Lifecore Biomedical (NASDAQ: LFCR), un'organizzazione di sviluppo e produzione a contratto (CDMO), ha programmato l'annuncio dei suoi risultati finanziari del secondo trimestre dell'anno fiscale 2025 per 2 gennaio 2025, dopo la chiusura del mercato. Il senior management dell'azienda condurrà un webcast alle 4:30 p.m. ora orientale per discutere i risultati trimestrali e i recenti sviluppi aziendali. Il webcast sarà accessibile attraverso il sito web delle relazioni con gli investitori di Lifecore, con una registrazione disponibile per almeno 14 giorni dopo la presentazione dal vivo.
Lifecore Biomedical (NASDAQ: LFCR), una organización de desarrollo y fabricación por contrato (CDMO), ha programado el anuncio de sus resultados financieros del segundo trimestre del año fiscal 2025 para el 2 de enero de 2025, después del cierre del mercado. La alta dirección de la compañía llevará a cabo un webcast a las 4:30 p.m. hora del Este para discutir los resultados trimestrales y los recientes desarrollos corporativos. El webcast será accesible a través del sitio web de relaciones con los inversores de Lifecore, con una repetición disponible durante al menos 14 días después de la presentación en vivo.
라이프코어 바이오메디컬 (NASDAQ: LFCR), 계약 개발 및 제조 조직 (CDMO),는 2025 회계연도 2분기 재무 실적 발표를 2025년 1월 2일, 시장 종료 후에 예정하고 있습니다. 회사의 고위 경영진은 동부 표준시 오후 4시 30분에 분기 결과 및 최근 기업 개발에 대해 논의하기 위한 웹캐스트를 주최할 것입니다. 웹캐스트는 라이프코어의 투자자 관계 웹사이트를 통해 접근할 수 있으며, 생중계 발표 후 최소 14일간 다시 볼 수 있는 녹화본이 제공됩니다.
Lifecore Biomedical (NASDAQ: LFCR), une organisation de développement et de fabrication sous contrat (CDMO), a programmé l'annonce de ses résultats financiers du deuxième trimestre de l'exercice 2025 pour le 2 janvier 2025, après la fermeture du marché. La haute direction de l'entreprise animera un webinaire à 16h30, heure de l'Est, pour discuter des résultats trimestriels et des récents développements de l'entreprise. Le webinaire sera accessible via le site web des relations investisseurs de Lifecore, avec une rediffusion disponible pendant au moins 14 jours après la présentation en direct.
Lifecore Biomedical (NASDAQ: LFCR), ein Unternehmen für Vertragsentwicklung und -herstellung (CDMO), wird die Bekanntgabe seiner Finanzergebnisse für das zweite Quartal des Geschäftsjahres 2025 für 2. Januar 2025, nach Marktschluss, planen. Das obere Management des Unternehmens wird um 16:30 Uhr Eastern Time einen Webcast veranstalten, um die Quartalsergebnisse und die aktuellen Unternehmensentwicklungen zu besprechen. Der Webcast wird über die Investor Relations-Website von Lifecore zugänglich sein, und eine Aufzeichnung wird für mindestens 14 Tage nach der Live-Präsentation verfügbar sein.
- None.
- None.
Webcast Scheduled for Thursday, January 2 at 4:30 p.m. Eastern
CHASKA, Minn., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it will report financial results for the second quarter of fiscal year 2025 on Thursday, January 2, 2025, after market close. At 4:30 p.m. Eastern Time that day, members of Lifecore’s senior management team will host a webcast to discuss financial results for the quarter and review recent corporate developments.
To listen to the live webcast, or access the archived webcast, please visit the Investor Events & Presentations page of Lifecore’s website at: https://ir.lifecore.com/events-presentations. Following the live webcast, a replay will be available on the company’s website for at least 14 days.
About Lifecore Biomedical
Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore’s website at www.lifecore.com.
FAQ
When will Lifecore Biomedical (LFCR) release Q2 2025 earnings?
What time is LFCR's Q2 2025 earnings webcast?
How can investors access LFCR's Q2 2025 earnings webcast?
How long will LFCR's Q2 2025 earnings webcast replay be available?
